Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NYSE - Delayed Quote USD

Hims & Hers Health, Inc. (HIMS)

Compare
29.55
+0.41
+(1.41%)
At close: March 31 at 4:00:02 PM EDT
29.32
-0.23
(-0.78%)
After hours: March 31 at 7:59:33 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Andrew Dudum Co-Founder, Chairman & CEO 1.98M 2.2M 1989
Mr. Oluyemi Okupe Chief Financial Officer 1.01M -- 1987
Ms. Melissa Baird Chief Operating Officer 1.05M 1.69M 1978
Ms. Soleil Teubner Boughton J.D. Chief Legal Officer & Corporate Secretary 928.7k 657.67k 1979
Dr. Patrick Carroll M.D. Chief Medical Officer & Director 54k -- 1958
Mr. Mike Chi Chief Commercial Officer 998k -- 1980
Ms. Irene A. Becklund Senior VP, Controller & Principal Accounting Officer 361.12k -- 1985
Ms. Khobi Brooklyn Chief Communications Officer -- -- --
Dr. Peter Stahl M.D. Senior Vice President of Men's Reproductive & Sexual Health -- -- --
Dr. Daniel Lieberman M.D. Senior Vice President of Mental Health -- -- --

Hims & Hers Health, Inc.

2269 Chestnut Street
Suite 523
San Francisco, CA 94123
United States
415 851 0195 https://www.hims.com
Full Time Employees: 
1,637

Description

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.

Corporate Governance

Hims & Hers Health, Inc.’s ISS Governance QualityScore as of March 1, 2025 is 10. The pillar scores are Audit: 5; Board: 9; Shareholder Rights: 10; Compensation: 10.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 5, 2025 at 10:59 AM UTC - May 9, 2025 at 12:00 PM UTC

Hims & Hers Health, Inc. Earnings Date

Recent Events

February 24, 2025 at 12:00 AM UTC

10-K: Periodic Financial Reports

November 21, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 7, 2024 at 12:00 AM UTC

SC 13G/A: Tender Offer/Acquisition Reports

November 4, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

October 22, 2024 at 12:00 AM UTC

SC 13G/A: Tender Offer/Acquisition Reports

August 5, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

July 22, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

June 10, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

June 6, 2024 at 12:00 AM UTC

8-K/A: Corporate Changes & Voting Matters

May 6, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers